Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Aug 17 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-17-2023-4

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 17, 2023, titled "Zydus receives final approval from the USFDA for Doxepin Tablets, 3 mg and 6 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases